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,N 2 ,O:N ]-zinc], on muscle function in the muscular dystrophy (mdx) mouse was examined by repetitive intraperitoneal administration in subjects aged 4 to 12 weeks. Z-103 administration at a dose of 150 mg/kg increased the load resistant time (LRT), during which the animal with a load holds itself upright on a wire net. The Z-103 administration reduced hypertrophy, the ratio of centronucleated myofibers, and the rate of decay for magnitude of twitch force elicited by 0.5 Hz of electricity to the extensor digitorum longus (EDL) muscle of 12-week-old mdx mice, with little effect on the magnitude of twitch force. The administration of Z-103 (100 mg/kg) had a lesser effect on LRT and the other characteristics examined for EDL muscles. The constituent of Z-103, Zn 2ϩ applied in the form of ZnSO 4 (5 mg/kg), carnosine (100 mg/kg), and the combination of the two had no beneficial effect on mdx mice. Z-103 (150 mg/kg) administered to normal mice increased LRT with little effect on the contractile properties of EDL muscles. These results suggest that the administration of Z-103 ameliorates muscle function in the mdx mouse. [Japanese Journal of Physiology, 52, 111-120, 2002] to the sarcolemma via dystrophin-glycoprotein complexes [16, 17] . Several bodies of evidence, however, suggest that the mislocation of nNOS does not contribute significantly to the degeneration of mdx muscle [18, 19] .
Pharmaceutical therapies have been tested on patients with DMD, and various therapeutic aspects have been examined in animal models over several decades. Among the drugs tested, glucocorticoids such as prednisone and deflazacort seem efficacious for the treatment of mdx muscle [20] [21] [22] , though the duration of their therapeutic effects and the risks of long-term drug use remain to be determined. Myoblast transplantation and gene regulation techniques are now being extensively applied to the treatment of mdx muscle [2] . Some therapeutics may be promising for DMD patients, but important issues such as clinical safety and hormonal and/or cellular immunological responses are still unresolved. Therefore the development of additional effective drugs to suppress or retard the degeneration of mdx muscle would be beneficial in combination with existing therapies.
Because of the susceptibility of mdx muscle to oxidative stress [14, 15] , many antioxidants have been examined on mdx muscle, but few have proved to be beneficial, resulting in some doubt about their effectiveness [23] . This study reports the effect of zinccarnosine chelate compound Z-103, catena-(
zinc], on mdx muscle, which exhibits antioxidative and membrane-stabilizing activities both in vitro and in vivo and is currently being used clinically as an antiulcer agent [24, 25] . Our findings show that the administration of Z-103 dose-dependently suppresses the degeneration of fast muscle and ameliorates the fatigue resistance of fast muscle and the mechanical performance of the mdx mouse, an experimental animal model for the study of DMD. To determine the mechanism underlying the effect of Z-103 on the mdx mouse, the present study also examined the effects of administering its constituents, Zn 2ϩ and carnosine, on the mdx mouse and the effect of Z-103 administration on normal mice.
MATERIALS AND METHODS
Preparation. C57BL/10 mdx and C57BL/10 ScSn normal mice were obtained from the Central Institute for Experimental Animals (Kawasaki, Japan). They were housed in cages in a room kept at a constant temperature (22°C) with a natural day-night light cycle in the Animal Laboratory at St. Marianna University. All animals were fed with a commercial cube diet and provided water ad libitum. Male mdx and normal mice were used in the present study and were treated in accordance with the Guiding Principles for the Care and Use of Animals approved by the Council of the Physiological Society of Japan.
Administration of chemicals. Z-103 has the following molecular formula, (C 9 H 12 N 4 O 3 Zn) n . Since the solubility of Z-103 is low (Ͻ0.01% in weight) in water at neutral pH, it was suspended in Ringer solution (in mM: NaCl 137, KCl 5, CaCl 2 2, MgCl 2 1, NaH 2 PO 4 1, NaHCO 3 25, glucose 10, pH 7.4). ZnSO 4 and carnosine (L-carnosine) were dissolved in Ringer solution. The chemical containing solution (10 l) was administered intraperitoneally (I.P.) to mice in a dosages given every other day, 3 times a week. Ringer solution was administered to the control group. The I.P. administration was begun at the age of 4 weeks and ended at 12 weeks. Doses are expressed as mg per kg body weight for mdx mice at each administration. Doses of Z-103 used in the present study were below the half lethal dose of 220 mg/kg for mouse [26] . Z-103 and carnosine were supplied by Hamari Chemicals Ltd. (Osaka, Japan).
Mechanical performance of whole animal. In a preliminary experiment, an escape test was performed to determine the ability of active force generation of the mdx mouse [27] . However, we were unable to reliably detect differences in whole body forces between mdx and normal mice. We subsequently developed a new test to determine the fatigability, instead of active force generating capability, of the whole animal. The mdx mice with a load equal to half their body weight attached to the tail by adhesive tape were put, standing upright, on a cylindrical wire net (4 cm in diameter and 20 cm long) 15 cm above the floor, and the time until they fell off (load resistance time, LRT) was measured. The LRT measurement was made only once unless it was too short; LRT measurements in second trials when required did not differ substantially from the initial values. LRT was measured once every week on days without drug administration.
Force measurement of muscles. The 12-week-old mdx mice were anesthetized with an I.P. injection of nembutal (50 mg/kg) with additional diether-ether anesthesia and then placed in dishes. After partial skinning of the hind limb, tendons of the extensor digitorum longus (EDL) muscle were cut at the knee and carefully separated from other surrounding muscles; the other end of the EDL muscle was left intact. The severed tendon was attached to a force transducer (Aker, AE801, Norway). The EDL muscle was placed between a pair of platinum wires and stimu-lated with 5 ms electrical pulses at 0.5 Hz, and EDL muscle was perfused by oxygenated Ringer solution at 37°C. Twitch force was recorded on an ink-printing oscillograph, after which the mdx mice were killed by cervical dislocation. EDL muscles were then removed and weighed.
Histology. EDL muscles not used in force measurement experiments were isolated, treated with OCT (optimal cutting temperature) compound (Tissue Tek, Sakura Finetechnical, Tokyo, Japan), immediately frozen in isopentane cooled by liquid nitrogen and stored at Ϫ80°C. Ten micrometer-thick transverse cryosections were cut from unfixed muscle at Ϫ25 to Ϫ20°C on a cryotome (Model 1500A, Lipshaw, Detroit, USA) at a point approximately midlength. Cryosections were mounted on coverslips, allowed to dry at room temperature, and stained with haematoxylin-eosin (HE). To assess muscle degenerationregeneration, a single section taken at midpoint of the muscle was selected, and muscle fibers in the cross section were counted visually from micrograph images on a monitor screen with a digital camera (HC300, Fujifilm, Tokyo, Japan) connected to a microcomputer. Fibers exhibiting centrally placed nuclei (centronucleated fibers) were considered to be regenerating fibers. Nuclei with no discernible surrounding cytoplasm were discarded. The ratio of regenerating to total myofibers was calculated for each EDL muscle examined.
Statistics. Since body weights and LRT were evaluated weekly for all mdx mice from 4 to 12 weeks of age, a repeated analysis of variance (ANOVA) was employed to determine any significant differences between experimental data from the mdx mice treatment and the control groups. Any significant effects between treatment and control groups were confirmed in each case by comparing mean values at each time point with Scheffe's F test. ANOVA with Scheffe's F test was also employed to determine the difference for the rate of decay in magnitude of twitch force over time in EDL muscle between mdx mice treatment and the control group. A Student's t-test was used to determine the significant differences in wet weight, magnitude of twitch force, and ratio of centronucleated fibers in EDL muscle. All experimental data are expressed as mean valuesϮSEM, and statistical significance was determined at the 5% level (pϽ0.05).
RESULTS

Development of mdx mouse
The effects of the chemicals used during the development of mdx mice were examined by a weekly measurement of body weights. Figure 1A shows the effect of Z-103 on body weights of mdx mice from the ages of 4 to 12 weeks. Z-103 at a dose of less than 100 mg/kg showed no significant effect on body weight, and it reduced the rates of increase in body weight later in the study period when the effects were examined at a dose of 150 mg/kg. The administrations of ZnSO 4 (5 mg/kg) and carnosine (100 mg/kg) and the combination of the two had little effect on body weight (Fig. 1B) .
LRT
As shown in Fig. 2A , control mdx mice showed
Effect of Z-103 on Mdx Mouse LRT values of 1-3 min throughout the age period examined, and normal mice exhibited LRT values of 20-40 min at the ages of 4-6 weeks and values over 50 min thereafter. The large difference in LRT between mdx and normal mice, together with the small variation in LRT values at each time point, especially among the mdx mice, suggest that LRT is a quite useful method for measuring muscle function of the whole animal. The administration of Z-103 at a dose of 100 mg/kg slightly increased LRT in mdx mice at a later phase in the period examined, and a dose of 150 mg/kg caused a transient, large increase in LRT 1 week after beginning the administration followed by a static increase ( Fig. 2A) . Z-103 at a dose of 50 mg/kg had no effect on LRT. ZnSO 4 at a dose of 5 mg/kg slightly increased the LRT in mdx mice, and carnosine at a dose of 100 mg/kg and in combination with ZnSO 4 exhibited little effect on LRT (Fig. 2B) .
EDL muscle
Normal EDL muscle shows both higher fatigability and higher susceptibility to contraction-induced injury, probably more a result of oxidative stress than of slow muscle (for a review, see Komulainen and Vihko [28] ). In mdx mouse, degeneration followed by regeneration is prominent in EDL muscles from the ages of 4 to 12 weeks [29] , resulting in hypertrophy and low force production of this muscle. To evaluate mechanical properties in muscle and the effects of chemicals on the degeneration-regeneration processes, the characteristics of EDL muscles were therefore examined in 12-week-old mdx mice, i.e., after an 8 week administration of the chemicals.
Weight. Figure 3A summarizes the effects of the chemicals used on the wet weight of EDL muscles from mdx mice. The wet weight of EDL muscle was greater in control mdx than in normal mice, as reported previously [30] . Among the chemicals exam-T. TAMEYASU et al. ined, only Z-103 at a dose of 150 mg/kg significantly decreased the wet weight of EDL muscle (pϽ0.05). That is, Z-103 reduced hypertrophy in mdx muscle.
Morphology. Muscle fibers before degeneration show peripheral nuclei, but regenerated fibers manifest central nuclei. Therefore the percentage of centronucleated fibers determined can be applied as an index of the degree of degeneration. Z-103 administration at doses of 100 and 150 mg/kg decreased the ratio of centronucleated fibers in a dose-dependent manner (Fig. 3B) , suggesting that Z-103 reduces mdx muscle degeneration. No detectable effects on the ratio of centronucleated fibers in EDL muscle were induced by ZnSO 4 or carnosine or their combination (Fig. 3B) .
Force. Because EDL muscle was stimulated with 0.5 Hz at 37°C, the twitch force decreased markedly with time (Fig. 4A) . To compare the magnitudes of twitch force among different EDL muscles, the maximum twitch force was normalized by the wet weight of the muscle instead of the cross-sectional area, because the determination of muscle length to estimate cross-sectional areas was not proved to be reliable. Figure 4B summarizes the effects of the chemicals applied on the magnitude of twitch force for EDL muscles from mdx mice. The EDL muscles of normal mice produced much greater twitch force than the EDL muscles of control mdx mice did, as reported previously [30] . Z-103 at doses of up to 150 mg/kg caused no effect on the magnitude of twitch force. The administration of ZnSO 4 alone decreased the magnitude of twitch force significantly (pϽ0.05), and Effect of Z-103 on Mdx Mouse Data from the EDL muscle of normal mice is also shown at right (indicated as normal). In B, the value of normal mice is 0.11Ϯ0.08. A statistical comparison was made against the control mdx mice. neither the mixture of ZnSO 4 with carnosine nor carnosine alone showed any effect. This finding suggests that carnosine reduces the toxic effect of ZnSO 4 in EDL muscle.
Fatigability. Since it is known that EDL muscle from mdx mice fatigues more rapidly when stimulated repeatedly when compared to normal mice [31] , the decay in magnitude of twitch force over time elicited at 0.5 Hz was compared between the EDL muscles from mdx mice administered Z-103 and other treatments and those from the control mice. As expected, the twitch force in EDL muscles from normal mice diminished much more slowly than in EDL muscles from control mdx mice (Fig.5A) . The administration of Z-103 at a dose of 150 mg/kg significantly delayed the decay of twitch force in EDL muscles from mdx mice (pϽ0.05), and a dose of 100 mg/kg evoked little effect over time (Fig. 5A) . The administrations of ZnSO 4 or carnosine or both in combination did not affect the time course of twitch force decay in mdx mice (Fig. 5B) . Consequently, only Z-103 at a dose of 150 mg/kg decreased fatigability in EDL muscle.
Normal mice
To explore the mechanism underlying the observed effects of Z-103 and ZnSO 4 on mdx mice, normal mice were administered Z-103 and ZnSO 4 from the age of 4 to 12 weeks by the same methods applied to mdx mice. As shown in Fig. 6A , neither Z-103 at doses of 100 nor 150 mg/kg nor ZnSO 4 at a dose of 5 mg/kg produced any significant effect on development as determined by body weight.
Since the LRT methodology was unreliable, especially after 8 weeks of age in normal mice, when measured in the same way for mdx mice ( Fig. 2A) , normal mice were loaded at the tail with a weight equal to individual body weight instead of half that amount. Figure 7 shows the effects of Z-103 or ZnSO 4 on wet weight, magnitude of twitch force, and fatigability in EDL muscles of 12-week-old normal mice. Neither Z-103 at doses up to 150 mg/kg nor ZnSO 4 at a dose of 5 mg/kg demonstrated any effects on EDL muscle when evaluated by these three characteristics.
DISCUSSION
In the mdx mouse, a degeneration of fibers followed by their regeneration occurs from the ages of 4 to 12 weeks in fast-type EDL muscle [29] , giving rise to hypertrophy, low force generation per cross-sectional area, and a slowing of contraction speed in this muscle. Z-103 administration reduced the ratio of centronucleated fibers in the EDL muscle of mdx mice (Fig. 3B) mdx muscle (Fig. 3A) . These results suggest that Z-103 administration ameliorates dysfunctional EDL muscle in the mdx mouse.
The fatigability of mdx muscle has been estimated by measuring the rate of decline of tetanic force at about 25°C [31] . To estimate the fatigability of EDL muscle at body temperature (37°C), and since it was difficult to obtain fused tetanus at such a high temperature, the time course of decline of twitch force evoked at 0.5 Hz was determined in the present study. Z-103 administration at a high dose reduced the fatigability of EDL muscle without affecting the magnitude of twitch force in mdx mice (Figs. 4 and 5A ), but no significant effects on these properties were shown in the EDL muscle of normal mice (Fig. 7) . The reduction of fatigability by Z103 may be related to the amelioration of both hypertrophy and degeneration of EDL muscle by Z-103, as described previously.
The analysis of causes of the large differences in LRT values between normal and mdx mice and other factor(s) affected by Z-103 administration warrants examination of the following determinants of LRT: (i) activity of motor nerves, (ii) signal transmission at neuromuscular junctions, (iii) muscle excitation, (iv) excitation-contraction coupling, (v) rate of muscle energy production, and (vi) type of muscle fiber. Among them, (ii)-(iv) are unlikely [1, 7, 8, 32] . In regard to (i), mental retardation observed in some patients with DMD and the mdx mouse is ascribed to the deficiency of brain dystrophin [33] . Therefore the suppression of motor nerve activity might also be implicated in the mdx mouse. Factors (v) and (vi) are related each other, since the rate of muscle energy production is closely related to oxygen supply and therefore to the muscle fiber type. LRT is principally a measure of the fatigability of slow muscles that are well supplied Effect of Z-103 on Mdx Mouse with capillaries. The vasodilator nitric oxide (NO) is produced by nNOS, which is mislocated in the mdx muscle [16, 17] ; subsequently the reduced NO synthesis may lead to insufficient vasodilation during exercise and result in reduced blood flow. That is, mdx muscles are more easily deficient in oxygen than normal muscles are during exercise. Further, slow and fast muscles isolated from mdx mouse both exhibit higher fatigability than normal muscles do (Fig. 5A ) [31] , though it is at present difficult to interpret the higher fatigability of the mdx muscles on the basis of muscle fiber type. For example, the slow soleus muscle of mdx mouse shows a higher proportion of slowtwitch oxidative fibers (type I) than normal muscles do, with a concomitant decrease in fast-twitch oxidative glycolytic fiber (type IIA) proportion [31] . One interpretation for this paradox is that the regenerative, centronucleated type I fiber may be different in fatigability from that with peripheral nuclei. Consequently, (v) and (vi) are likely interpretations for the current findings.
In this study, the administration of Z-103 at a dose of 150 mg/kg biphasically increased LRT in the mdx mouse; an initial transient increase in the LRT was followed by a smaller static one ( Fig. 2A) . Since the static effect of Z-103 was also observed in normal mice, this effect may not be related to the absence or presence of dystrophin. Because mice were subjected to the LRT measurement only once a week in this study, it is unlikely that the LRT measurement itself was influenced by any training effect on the muscles involved. The mechanism by which Z-103 enhances LRT in normal mice is uncertain. For the present purpose, this subject was not considered in detail.
The marked increase in LRT 1 week after starting Z-103 administration at a dose of 150 mg/kg was specific to mdx mice. This might have been due to the reduced degeneration of EDL muscle by Z-103 ( tractile properties of the muscle itself. So far, however, no evidence suggests which factor (i), (v), or (vi) might be affected by Z-103 administration.
It is still a matter of controversy whether antioxidants have beneficial effects on mdx muscle, even though the mdx muscle is quite susceptible to oxidative stress [10, 24] . The discrepancy about the effect of antioxidants on mdx muscle among research groups may be ascribed not only to the condition of research, but also to the species of antioxidants used, since reactive oxygen species are produced by various metabolic processes in situ and extrinsic and intrinsic antioxidants both function in various ways. Z-103 has antioxidative actions such as the inhibition of superoxide generation from polymorphonuclear leukocytes both in vitro and in vivo [24, 25] . It was recently reported that in cell culture, Z-103 proliferates some of cells by affecting an insulin-like growth factor [34] , suggesting a complex action of Z-103 in situ. Because of very low solubility of Z-103 in water at neutral pH, the production of Zn 2ϩ and carnosine from the administered Z-103 might be very small, if any, in situ. Though the administration of ZnSO 4 increased LRT slightly in mdx mice (Fig. 2B) , it decreased twitch force without ameliorating either the hypertrophy or the degeneration of the EDL muscle of mdx mouse (Figs. 3 and 4) . The administration of either carnosine alone or carnosine in combination with ZnSO 4 caused no similar beneficial effect on mdx mice compared with Z-103. Further, the amounts of both Zn 2ϩ and carnosine are normal in the mdx mouse. Therefore, it seems reasonable to ascribe the observed beneficial effect of Z-103 administration on muscle function in the mdx mouse to Z-103 itself.
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